BioSpace News Archive

The AI in Advancement Advisory Council (AAAC), a first-of-its-kind organization committed to open discussion and evaluation about where Artificial Intelligence (AI) can and should have an impact on advancement, today announced its second cohort, adding eleven new members to the Council.

Feb. 24, 2020 13:30 UTC Zymeworks to Present at Raymond James 41 st Annual Institutional Investors Conference VANCOUVER, British Columbia--( BUSINESS WIRE )-- Zymeworks Inc. (NYSE:ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that the Company will present at the upcoming Raymond James Institutional Investors Conference taking place March 1-4, 2020 in Orlando, FL. The Company’s presentation will be on Monday, March 2

Feb. 24, 2020 13:30 UTC – MGTA-117 ADC clinical candidate for conditioning showed broad tolerability and wide pre-clinical safety margins – – MGTA-117 demonstrated robust anti-tumor activity in xenograft models from patients with refractory leukemia – – Magenta plans to move MGTA-117 into the clinic with initial clinical data in 2021 – – Landmark data with tool CD117-ADC demonstrate first successful gene therapy transplant without chemotherapy in non-human primates, awar

Feb. 24, 2020 13:30 UTC – Updated data from the Phase 1 study in healthy subjects show that MGTA-145, in combination with plerixafor, met all primary and secondary endpoints – – Median of 4.1 million CD34+ cells/kg collected in a single day from eight subjects – – Magenta plans to initiate multiple Phase 2 studies in 2020, in both allogeneic and autologous transplant settings – CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Magenta Therapeutics (NASDAQ: MGTA), a clinical

LogiTag Medical Solutions announced the launch of its patent-protected Snap & Go image recognition technology that captures, records and bills medical implants and consumables used during surgery.

Trinity Life Sciences, a global life sciences commercialization solutions provider with extensive experience in launch planning, is sharing lessons learned in its latest report, “Achieving Launch Excellence in this New Decade: Four Must-Haves for an Agile Launch Strategy.”

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced that management will present at four upcoming investor conferences

The Medical Affairs Professional Society, the premier non-profit global society of Medical Affairs professionals, announces the first major expansion of its Board of Directors.

Aetna, a CVS Health company, is now offering fully insured and self-insured health care network options to its Health Maintenance Organization and Exclusive Product Organization product portfolios through Aetna Whole HealthSM – Atlanta.

Feb. 24, 2020 13:55 UTC IRVINE, Calif.--( BUSINESS WIRE )-- Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into an exchange agreement with three holders of the Company’s 3.25% Senior Convertible Notes due 2020 (the “Existing Notes”), pursuant to which these investors exchanged an aggregate of approximately $11.0 million of the Existing Notes plus accrued inte